Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

TOP - May 2010 Vol 3, No 3

TOP - May 2010 Vol 3, No 3 published on June 9, 2010

Severe hypersensitivity reactions to antineoplastic agents are quite rare, occurring 5% of the time across all agents.1 Despite this, the impact to the patient can be quite significant, resulting in discomfort and distress, hospitalization, treatment discontinuation, and even death. Unlike most adverse reactions, which often can be predicted, infusion reactions are unexpected and variable. Although rare, nearly every antineoplastic drug has been associated with a hypersensitivity reaction.

Page 2 of 2
Results 11 - 11 of 11